Acadia Healthcare (NASDAQ:ACHC) Sets New 12-Month Low – Should You Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price reached a new 52-week low during trading on Wednesday . The stock traded as low as $50.93 and last traded at $51.11, with a volume of 145694 shares changing hands. The stock had previously closed at $51.66.

Analyst Ratings Changes

ACHC has been the topic of a number of recent research reports. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft boosted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. KeyCorp assumed coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. Finally, Barclays lowered their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat, Acadia Healthcare currently has an average rating of “Hold” and an average target price of $86.67.

Acadia Healthcare Trading Up 0.9 %

The firm has a market cap of $4.75 billion, a P/E ratio of -365.86, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. The business’s 50 day moving average is $69.06 and its 200-day moving average is $68.89. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.92 EPS. As a group, analysts forecast that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Blue Trust Inc. raised its position in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Acadia Healthcare in the 2nd quarter worth about $59,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at about $86,000. Finally, nVerses Capital LLC bought a new stake in shares of Acadia Healthcare during the 2nd quarter valued at about $95,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.